Amanote Research

Amanote Research

    RegisterSign In

Cediranib in Glioblastoma

doi 10.2174/978160805132811001010176
Full Text
Open PDF
Abstract

Available in full text

Date

March 28, 2012

Authors
Elizabeth R. GerstnerJorg H. DietrichDaphne WangTracy T. Batchelor
Publisher

BENTHAM SCIENCE PUBLISHERS


Related search

Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma

Cancer Research
Cancer ResearchOncology
2011English

Cediranib Is Effective in Alveolar Soft Part Sarcoma

Cancer Discovery
Oncology
2013English

Phase II Study of Cediranib in Patients With Malignant Pleural Mesothelioma: SWOG S0509

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

MicroRNAs in Cancer: Glioblastoma and Glioblastoma Cancer Stem Cells

Neurochemistry International
Molecular NeuroscienceCell BiologyCellular
2014English

Immunological Evasion in Glioblastoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2016English

Ion Channels in Glioblastoma

ISRN Neurology
2011English

Cediranib With mFOLFOX6 vs Bevacizumab With mFOLFOX6 in Previously Treated Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2013English

Faculty Opinions Recommendation of Cediranib for Metastatic Alveolar Soft Part Sarcoma.

2013English

Glioblastoma in 140 Characters

Neurology
Neurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy